Sébastien G.
- Country
- France
- Department
- Medical oncology
Research Overview
- Phase III Study on Laryngeal Preservation in Locally Advanced Squamous Cell Carcinomas of the Larynx or Hypopharynx: Comparing Induction Chemotherapy with Cisplatin, 5-Fluorouracil, and Docetaxel Followed by Radiotherapy Versus Concomitant Radiotherapy with Cisplatin.
- Phase II Evaluation of Durvalumab Combined with Radiotherapy in T1-T4 N0-N2b Squamous Cell Carcinoma of the Head and Neck Without Prophylactic Neck Irradiation
Data & Insights
Has run more than one trial at 7 of 34 partner sites.
Specializations
Head and Neck Oncology
The investigator specializes in treating head and neck cancers, with particular expertise in squamous cell carcinomas. Their research encompasses innovative therapeutic approaches for managing various stages of these conditions.
- Advanced laryngeal cancer management
- Hypopharyngeal cancer treatment
- Cervical lymph node interventions
Primary focus includes organ preservation strategies for laryngeal structures.
Therapeutic Combinations
Expertise in developing integrated treatment approaches combining immunotherapy with radiotherapy. The investigator explores targeted therapeutic strategies for improving patient outcomes.
- Combined modality treatments
- Regional control optimization
- Tumor site-specific therapy
Special interest in personalized treatment protocols for localized tumors.
Organ Preservation
Dedicated to advancing laryngeal preservation techniques through innovative therapeutic combinations. Focus on maintaining functional outcomes while delivering effective cancer treatment.
- Laryngeal function preservation
- Pharyngoesophageal dysfunction prevention
- Quality of life optimization
Emphasis on developing strategies that balance treatment efficacy with organ function.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.